☰

Achim K. Moesta, Ph.D. - Publications

Affiliations: 
2008 Stanford University, Palo Alto, CA 
Area:
Immunology
Tree Info Grants Similar researchers PubMed Report error

16 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Yan J, Li XY, Roman Aguilera A, Xiao C, Jacoberger-Foisac C, Nowlan B, Robson SC, Beers C, Moesta AK, Geetha N, Teng MWL, Smyth MJ. Control of metastases via myeloid CD39 and NK cell effector function. Cancer Immunology Research. PMID 31992567 DOI: 10.1158/2326-6066.Cir-19-0749  0.319
2019 Lerner AG, Kovalenko M, Welch M, Cruz Td, Jones J, Wong C, Spatola B, Eberhardt M, Wong A, Fung W, Lagpacan L, Losenkova K, Yegutkin G, Soros V, Corbin J, ... ... Moesta AK, et al. Abstract 5012: Targeting CD39 with a first-in-class inhibitory antibody prevents ATP processing and increases T-cell activation Cancer Research. 79: 5012-5012. DOI: 10.1158/1538-7445.Am2019-5012  0.301
2015 Hilton HG, Moesta AK, Guethlein LA, Blokhuis J, Parham P, Norman PJ. The production of KIR-Fc fusion proteins and their use in a multiplex HLA class I binding assay. Journal of Immunological Methods. 425: 79-87. PMID 26096968 DOI: 10.1016/J.Jim.2015.06.012  0.689
2012 Moesta AK, Parham P. Diverse functionality among human NK cell receptors for the C1 epitope of HLA-C: KIR2DS2, KIR2DL2, and KIR2DL3. Frontiers in Immunology. 3: 336. PMID 23189078 DOI: 10.3389/Fimmu.2012.00336  0.811
2012 Hilton HG, Vago L, Older Aguilar AM, Moesta AK, Graef T, Abi-Rached L, Norman PJ, Guethlein LA, Fleischhauer K, Parham P. Mutation at positively selected positions in the binding site for HLA-C shows that KIR2DL1 is a more refined but less adaptable NK cell receptor than KIR2DL3. Journal of Immunology (Baltimore, Md. : 1950). 189: 1418-30. PMID 22772445 DOI: 10.4049/Jimmunol.1100431  0.799
2010 Abi-Rached L, Moesta AK, Rajalingam R, Guethlein LA, Parham P. Human-specific evolution and adaptation led to major qualitative differences in the variable receptors of human and chimpanzee natural killer cells. Plos Genetics. 6: e1001192. PMID 21079681 DOI: 10.1371/Journal.Pgen.1001192  0.779
2010 Older Aguilar AM, Guethlein LA, Adams EJ, Abi-Rached L, Moesta AK, Parham P. Coevolution of killer cell Ig-like receptors with HLA-C to become the major variable regulators of human NK cells. Journal of Immunology (Baltimore, Md. : 1950). 185: 4238-51. PMID 20805421 DOI: 10.4049/Jimmunol.1001494  0.808
2010 Moesta AK, Graef T, Abi-Rached L, Older Aguilar AM, Guethlein LA, Parham P. Humans differ from other hominids in lacking an activating NK cell receptor that recognizes the C1 epitope of MHC class I. Journal of Immunology (Baltimore, Md. : 1950). 185: 4233-7. PMID 20802150 DOI: 10.4049/Jimmunol.1001951  0.802
2010 Parham P, Abi-Rached L, Matevosyan L, Moesta AK, Norman PJ, Older Aguilar AM, Guethlein LA. Primate-specific regulation of natural killer cells. Journal of Medical Primatology. 39: 194-212. PMID 20618586 DOI: 10.1111/J.1600-0684.2010.00432.X  0.764
2009 Graef T, Moesta AK, Norman PJ, Abi-Rached L, Vago L, Older Aguilar AM, Gleimer M, Hammond JA, Guethlein LA, Bushnell DA, Robinson PJ, Parham P. KIR2DS4 is a product of gene conversion with KIR3DL2 that introduced specificity for HLA-A*11 while diminishing avidity for HLA-C. The Journal of Experimental Medicine. 206: 2557-72. PMID 19858347 DOI: 10.1084/Jem.20091010  0.73
2009 Gendzekhadze K, Norman PJ, Abi-Rached L, Graef T, Moesta AK, Layrisse Z, Parham P. Co-evolution of KIR2DL3 with HLA-C in a human population retaining minimal essential diversity of KIR and HLA class I ligands. Proceedings of the National Academy of Sciences of the United States of America. 106: 18692-7. PMID 19837691 DOI: 10.1073/Pnas.0906051106  0.749
2009 Norman PJ, Abi-Rached L, Gendzekhadze K, Hammond JA, Moesta AK, Sharma D, Graef T, McQueen KL, Guethlein LA, Carrington CVF, Chandanayingyong D, Chang YH, Crespí C, Saruhan-Direskeneli G, Hameed K, et al. Meiotic recombination generates rich diversity in NK cell receptor genes, alleles, and haplotypes Genome Research. 19: 757-769. PMID 19411600 DOI: 10.1101/Gr.085738.108  0.69
2009 Moesta AK, Abi-Rached L, Norman PJ, Parham P. Chimpanzees use more varied receptors and ligands than humans for inhibitory killer cell Ig-like receptor recognition of the MHC-C1 and MHC-C2 epitopes. Journal of Immunology (Baltimore, Md. : 1950). 182: 3628-37. PMID 19265141 DOI: 10.4049/Jimmunol.0803401  0.805
2009 Hammond JA, Guethlein LA, Abi-Rached L, Moesta AK, Parham P. Evolution and survival of marine carnivores did not require a diversity of killer cell Ig-like receptors or Ly49 NK cell receptors. Journal of Immunology (Baltimore, Md. : 1950). 182: 3618-27. PMID 19265140 DOI: 10.4049/Jimmunol.0803026  0.62
2008 Moesta AK, Norman PJ, Yawata M, Yawata N, Gleimer M, Parham P. Synergistic polymorphism at two positions distal to the ligand-binding site makes KIR2DL2 a stronger receptor for HLA-C than KIR2DL3. Journal of Immunology (Baltimore, Md. : 1950). 180: 3969-79. PMID 18322206 DOI: 10.4049/Jimmunol.180.6.3969  0.817
2004 Bankovich AJ, Girvin AT, Moesta AK, Garcia KC. Peptide register shifting within the MHC groove: theory becomes reality. Molecular Immunology. 40: 1033-9. PMID 15036907 DOI: 10.1016/J.Molimm.2003.11.016  0.373
Show low-probability matches.